Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice - Report - MDSpire
Advertisement
Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice
Clinical Report: Classification, cancer-causing mechanisms, and diagnostics of Fusobacterium nucleatum in colorectal cancer
Overview
Fusobacterium nucleatum (Fn) is identified as an oncogenic organism linked to colorectal cancer (CRC), influencing tumorigenesis through various mechanisms.
Background
Colorectal cancer is a leading cause of cancer mortality, and understanding the role of Fusobacterium nucleatum in its pathogenesis is crucial for developing effective diagnostic and therapeutic strategies.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
Fusobacterium nucleatum is implicated in colorectal cancer through oncogenic signaling activation and immune microenvironment modulation.
Technological advancements have improved Fn detection methods, transitioning from culture-based assays to high-resolution techniques.
Fn's presence is associated with dysbiosis and may contribute to tumor progression and poor treatment outcomes.
Current clinical guidelines do not incorporate Fn or microbiome-based assays in CRC diagnostics.
Research indicates that specific Fn subspecies may dominate CRC niches.
Clinical Implications
The integration of Fusobacterium nucleatum detection into clinical practice is under investigation, but challenges in standardization of diagnostic platforms exist.
Conclusion
Fusobacterium nucleatum represents a significant area of research in colorectal cancer.
